botulinum toxin

Also found in: Dictionary, Medical, Financial, Acronyms, Encyclopedia, Wikipedia.
Graphic Thesaurus  🔍
Display ON
Animation ON
  • noun

Words related to botulinum toxin

any of several neurotoxins that are produced by the anaerobic bacterium Clostridium botulinum

References in periodicals archive ?
Exactly what animal this ninth botulinum toxin is meant to target remains unknown.
Currently, botulinum toxin has been shown effective in the treatment of gummy smile in patients with hyperfunction of the muscles involved in smiling, as well as in patients with other disorders such as temporomandibular disorders (hypertrophy of the masseter muscle, bruxism, clench) and myofascial pain (1, 6, 9).
In cases where masseter hypertrophy causes appositional changes in the bone, the success rate with botulinum toxin treatment alone is low, and the surgical option should be considered.
Botulinum toxin is currently preferred as a minimally invasive treatment in the treatment of lower urinary tract pathologies.
In contrast to other mature protocols for botulinum toxin A application, local botulinum toxin A injection into the diaphragm is a novel attempt.
treated 14 patients with facial nerve paralysis using botulinum toxin. The injection sites were the contralateral lower facial muscles (elevator and depressor angularis oris).
According to market intelligence firm Global Industry Analysts Inc., the global botulinum toxin market is projected to reach USD6.6bn by 2022.
Between December 2014 to January 2017, we treated 29 patients with spasticity caused by different neurological conditions with a combination of aqueous phenol and botulinum toxin injections.
Botulinum toxin (Botox) is an exotoxin produced by the bacterium Clostridium botulinum, which blocks acetylcholine release from cholinergic nerve endings into the neuromuscular junction, thereby causing inactivity of muscles or glands [6].
Keywords: Botulinum toxin, blepharospasm, hemifacial spasm, strabismus
Summary: This report analyzes the current and future scenario of the global Botulinum Toxin Market.
A botulinum toxin serotype E in the pipeline for treatment of glabellar lines has a rapid onset of action--within 24 hours--yet a response duration of only 2 to 4 weeks.